WO2000078710A1 - Method of making hydroxylamine salts - Google Patents

Method of making hydroxylamine salts Download PDF

Info

Publication number
WO2000078710A1
WO2000078710A1 PCT/US2000/017155 US0017155W WO0078710A1 WO 2000078710 A1 WO2000078710 A1 WO 2000078710A1 US 0017155 W US0017155 W US 0017155W WO 0078710 A1 WO0078710 A1 WO 0078710A1
Authority
WO
WIPO (PCT)
Prior art keywords
oxime
alkylating
hydroxylamine salt
group
ether
Prior art date
Application number
PCT/US2000/017155
Other languages
French (fr)
Other versions
WO2000078710A8 (en
Inventor
Xun Li
Indira Reddy
Mohammad Aslam
Baihua Wu
Original Assignee
Alliedsignal Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliedsignal Inc. filed Critical Alliedsignal Inc.
Priority to AU56318/00A priority Critical patent/AU5631800A/en
Publication of WO2000078710A1 publication Critical patent/WO2000078710A1/en
Publication of WO2000078710A8 publication Critical patent/WO2000078710A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08Hydroxylamino compounds or their ethers or esters
    • C07C239/20Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified

Definitions

  • the present invention relates to methods for the production of hydroxylamine salts.
  • Hydroxylamine salts are of particular interest for use in the syntheses of numerous pharmaceutical drug candidates.
  • antihistaminic agents and other drugs used in the treatment of heart failure and hypertension may be synthesized using hydroxylamine salts.
  • Applicants believe that known methods for making hydroxylamine salts are highly inefficient, often using disfavored reaction ingredients and/or reaction conditions.
  • one known prior art processes for forming hydroxylamines comprises reacting an oxime and alkylating agent in the presence of sodium amide or sodium ethoxide in benzene or ethanol for extended periods of time (e.g. 12-24 hours), and then subjecting the reaction product to hydrolysis conditions for an additional extended period of time (e.g. 15 hours).
  • Such processes are reported have produced yields of hydroxylamine salts of only about 23 % or less. See Bozdag, O. et al, "Synthesis of some novel oxime ether derivatives and their activity in the 'behavioral despair test'" Eur. J. Med. Chem., 33, 133-141 (1998).
  • the present invention is directed to methods of producing a wide range of hydroxlamine salts, many of which find particular use in the syntheses of pharmaceutical drug candidates used as antihistaminic agents and/or in the treatment of heart failure and hypertension.
  • the present methods generally involve the steps of (a) reacting an oxime with an oxime
  • reaction (a) is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl)
  • NMP pyrrolidinone
  • hydrolization reaction step (b) comprises reacting the oxime ether at
  • the present methods comprise (a) reacting an
  • yield refers
  • the present invention produce the desired hydroxylamine salts in much shorter periods of
  • any oxime reactant known in the art can be adapted for use in accordance with the present invention.
  • a large number of oximes are commercially available.
  • oximes as illustrated in
  • R, and R 2 are independently selected from the group consisting of hydrogen,
  • R, or R 2 as an unsubstituted or substituted alkyl group may be straight-chained or
  • branched for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, hexyl,
  • R, or R 2 as an unsubstituted or substituted alkyl group is an
  • alkyl having about 1 to about 12 carbons for example, methyl, ethyl, propyl, isopropyl,
  • R, or R 2 as an unsubstituted or
  • substituted alkyl group is either methyl or ethyl.
  • R, or R 2 as an unsubstituted or substituted cycloalkyl may be, for example,
  • R methylcyclohexyl, dimethylcyclohexyl, cycloheptyl, and cyclohexyl.
  • R, or R 2 are methylcyclohexyl, dimethylcyclohexyl, cycloheptyl, and cyclohexyl.
  • R, or R 2 are methylcyclohexyl, dimethylcyclohexyl, cycloheptyl, and cyclohexyl.
  • cycloalkyl as an unsubstituted or substituted cycloalkyl is cyclopentyl, cyclopentadienyl or cyclohexyl.
  • R, or R 2 as an unsubstituted or substituted aryl group may be, for example, phenyl,
  • R, or R 2 as
  • an unsubstituted or substituted aryl group is an aryl group having about 6 to about 10 carbons, such as, phenyl or napthyl.
  • R, or R 2 as an unsubstituted or substituted aralkyl group may be, for example,
  • benzyl methylbenzyl, methoxybenzyl, diphenylmethyl, phenylethyl, or phenylpropyl.
  • R, or R 2 as an unsubstituted or substituted aralkyl group is an aralkyl having
  • Particularly preferred oximes include acetoxime, benzaldehyde oxime, and methyl
  • alkylating agent refers to any material capable of providing to the reaction a nucleophilic alkyl, aryl, aralkyl or cycloalkyl group capable of reacting with the oxime to form an oxime ether.
  • the nucleophilic group provided by the alkylating agent or agents may be unsubstituted or subtituted and may contain heteroatoms. Examples of suitable alkylating agents include: 2-(N,N-Dimethylamino)ethyl chloride
  • Preferred alkylating agents include: 2-(N,N-Dimethylamino)ethyl chloride hydrochloride,
  • agent comprises 2-(N,N-Dimethylamino)ethyl chloride hydrochloride.
  • the oxime alkylation reaction of the present invention is conducted under conditions effective to convert at least a portion of the oxime starting material, and preferably at least about 45 % (on a mole basis) of the oxime to oxime ether.
  • conditions effective to convert at least a portion of the oxime starting material and preferably at least about 45 % (on a mole basis) of the oxime to oxime ether.
  • the particular temperatures, pressures and other reaction conditions can vary widely within the scope of the present invention, depending on factors such as the particular starting material being used, the process equipment available and the particular hydroxylamine salt
  • the oxime alkylation reaction take place in an inert solvent.
  • any known inert solvent can be used with some degree of effectiveness in accordance with the present invention.
  • the oxime reaction is preferred.
  • undesirable halide salt side products formed in the oxime reaction (a) are generally
  • the other conditions for conducting the oxime reaction can be selected as required for each individual application in view of the description of the invention contained herein.
  • the relative amounts of the oxime and alkylating agent to be used in the practice of the present invention it is believed that this can vary widely depending on the particulars of each application, including the particular oxime starting material and the desired yield from the oxime reaction step (a).
  • the relative amount of starting materials used, together with the other process condition, as described herein are effective to achieve a greater than 50% yield (on a mole basis) of oxime ether.
  • the oxime starting material comprises acetoxime and the alkylating agent is 2-(N,N-Dimethylamino)ethyl chloride hydrochloride
  • the mole ratio of oxime to alkylating agent is preferably at least about 1:2, more preferably
  • the oxime reaction (a) comprises
  • suitable base soluble in the solvent can be used.
  • the present invention include: sodium hydroxide, potassium hydroxide, sodium carbonate,
  • the base comprises sodium
  • sodium hydroxide and potassium hydroxide are especially useful in the form of a
  • reaction solvent and increase the reaction surface between the base, the alkylating agent and
  • the base comprises a fine powder of sodium hydroxide or potassium hydroxide.
  • the relative amount of base to be used in the preferred practice of the present invention can also vary widely within the scope hereof.
  • the oxime starting material comprises acetoxime and the alkylating agent is 2-(N,N-
  • Dimethylamino)ethyl chloride hydrochloride the mole ratio of oxime to base is preferably
  • the conditions under which the alkylation reaction occurs can vary widely within the scope hereof, depending on numerous factors, including the particular starting materials used.
  • oxime reactions of the present invention will require shorter periods of time to complete than prior art processes.
  • the alkylating agent is 2-(N,N-Dimethylamino)ethyl chloride hydrochloride, it is preferred that the reaction time
  • the alkylating reaction be about 10 hours or less. More preferably, the reaction time is about 8 hours or less, and even more preferably 6 hours or less. In view of the teachings contained herein, those skilled in the art will be able to select the appropriate reaction conditions to achieve the particular desired result.
  • the alkylating reaction is preferably carried
  • the alkylating reaction is preferably carried out at pressures of from about 1 to about 3
  • atmospheres more preferably from about 1 to about 2 atm. and even more
  • the oxime ether compounds obtained from the aforementioned reaction may be any suitable oxime ether compounds obtained from the aforementioned reaction.
  • washes, drying, concentrating under reduced pressure, distillation, and the like may be
  • reaction step (a) the products of reaction step (a)
  • solvent including up to about 95 % or more can be recovered during distillation and
  • the second step of the present methods comprises reacting the oxime ether with a hydrolyzing agent to form the desired hydoxylamine salts.
  • the preferred hyrolyzing agents according to the present invention comprise a liquid, and even more preferably an acid dissolved in a liquid solvent.
  • the step (b) comprises dissolving the oxime ether in the hydrolyzing agent and exposing the reactants to conditions effective to produce the desired hydroxlamine salt.
  • any known acid and solvent used conventionally in acid-catalyzed hydrolysis reactions can be used in the present invention.
  • acids suitable for use in the present invention include hydrochloric acid and sulfuric acid.
  • the hydrolyzing agent comprises a 20% solution of hydrochloric acid in water.
  • hydrolysis reaction temperature within a defined range.
  • the hydrolysis reaction may be conducted generally at temperatures used in prior art hydrolyses, applicants have discovered that by conducting the hydrolysis reaction at a temperature above the boiling point of the hydrolyzing agent, but below the decomposition temperatures of the oxime ether and the hydroxylamine salts, a significantly higher yield of product can be formed in a significantly shorter time than had been available with prior art processes.
  • the term "decomposition temperature" of a compound refers generally to the temperature at which, under the reaction pressure, the compound breaks down into smaller constituents.
  • the term "boiling point" as used herein means the initial boiling point of the hydrolyzing agent at the pressure of the reaction.
  • the reaction mixture will develop an undesirably high concentration of the ketone or aldehyde side-products, which are formed by hydrolyzing the carbon-nitrogen imine bond of the oxime ether. It is believed that the presence of these side products inhibits the formation of the desired hydroxylamine salts. As illustrated in the reaction equation below, the hydrolysis reaction is an equilibrium reaction.
  • the temperature at which the hydrolysis reaction is conducted is maintained below the decomposition points of the oxime ether and the desired hydroxylamine salt.
  • the reflux temperature is at least 45 °C below the lower decomposition point, and even more preferably, 60 °C below.
  • the reflux temperature is at least 45 °C below the lower decomposition point, and even more preferably, 60 °C below.
  • oxime ether 2-(N,N-Dimethylamino)ethyl acetoxime ether and the desired
  • hydroxylamine salt is O-[2-N,N-dimethylamino)ethyl]-hydroxylamine dihydrochloride
  • reaction temperature is preferably from about 105°C to about 120°C. More preferably, the
  • reaction temperature of the preferred processes is from about 108°C to about 115°C
  • the period of reaction can vary widely within the scope hereof, depending on numerous factors, including the particular starting materials used. However, in general, it is believed oxime ether reactions of the present invention will require shorter periods of time to complete than prior art processes. For preferred processes in which the oxime ether starting material comprises 2-(N,N-Dimethylamino)ethyl acetoxime, it is preferred that the reaction
  • the time of the alkylation reaction be about 12 hours or less. More preferably, the reaction time is about 10 hours or less, and even more preferably 8 hours or less. In view of the teachings contained herein, those skilled in the art will be able to select the appropriate reaction conditions to achieve the particular desired result.
  • hydrolysis reaction of the present invention be conducted according to the teachings hereof so as to provide an hydroxylamine salt yield of at least
  • the hydroxylamine salt compounds obtained from the aforementioned reaction may be any suitable hydroxylamine salt compounds obtained from the aforementioned reaction.
  • the hydrolysis reaction is carried out in a vessel
  • preferred solvent for use in recrystallization of hydroxylamine salts is methanol.
  • Acetone oxime (511.6 g, 7.0 mol) was charged as one portion and the resulting mixture
  • reaction was agitated at 65-70 °C for 1.5 hours and was then monitored by
  • the cooling fluid temperature was set at 0°C.
  • the solution was heated to gentle reflux
  • distillate was gathered.
  • the pot temperature was raised to 105°C and the vacuum was gradually decreased to 90 mmHg.
  • the distillates (50mL/per cut) were checked carefully by
  • DMAEHA-2HC1 hydroxylamine dihydrochloride
  • thermocouple thermocouple, a dropping funnel and a condenser connected to both a receiver and a caustic
  • butanol (1.8L, b.p. 118°C) was added. The mixture was heated to reflux (jacket).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A method for producing hydroxylamine salts by using oximes as a principal reagent and which proceeds through the hydrolyzation of an oxime ether.

Description

METHOD OF MAKING HYDROXYLAMINE SALTS FIELD OF INVENTION
The present invention relates to methods for the production of hydroxylamine salts. BACKGROUND OF INVENTION
Hydroxylamine salts are of particular interest for use in the syntheses of numerous pharmaceutical drug candidates. For example, antihistaminic agents and other drugs used in the treatment of heart failure and hypertension may be synthesized using hydroxylamine salts.
Applicants believe that known methods for making hydroxylamine salts are highly inefficient, often using disfavored reaction ingredients and/or reaction conditions. For example, one known prior art processes for forming hydroxylamines comprises reacting an oxime and alkylating agent in the presence of sodium amide or sodium ethoxide in benzene or ethanol for extended periods of time (e.g. 12-24 hours), and then subjecting the reaction product to hydrolysis conditions for an additional extended period of time (e.g. 15 hours). Such processes are reported have produced yields of hydroxylamine salts of only about 23 % or less. See Bozdag, O. et al, "Synthesis of some novel oxime ether derivatives and their activity in the 'behavioral despair test'" Eur. J. Med. Chem., 33, 133-141 (1998).
The present inventors have come to appreciate that prior art processes of the type disclosed in Eur. J. Med. Chem., 33, 133-141 (1998) are disadvantageous for several reasons. In addition to long reaction times and low yields, another disadvantage of the prior art process is that benzene is a cancer suspect agent and thus may be dangerous to work with, especially in industrial scale conditions.
Recognizing these and other drawbacks of the prior art, the present inventors have perceived a need for a new, efficient and more desirable method for producing a wide range of hydroxylamine salts. These and other objects are achieved by the present invention as described below.
DESCRIPTION OF THE INVENTION AND PREFERRED EMBODIMENTS
The present invention is directed to methods of producing a wide range of hydroxlamine salts, many of which find particular use in the syntheses of pharmaceutical drug candidates used as antihistaminic agents and/or in the treatment of heart failure and hypertension.
The present methods generally involve the steps of (a) reacting an oxime with an
alkylating agent to produce an oxime ether; and (b) reacting at least a portion of the oxime
ether with a hydrolizing agent to form a hydroxylamine salt. We have discovered that
unexpectedly beneficial results can be obtained by conducting the oxime reaction step (a) in
the presence of a solvent that enhances the relative speed and completeness of the reaction.
According to preferred embodiments of this aspect of the invention, the reaction (a) is
carried out in the presence of a solvent selected from the group consisting of l-methyl-2-
pyrrolidinone ("NMP"), acetonitrile and combinations of these
We have also discovered that the proper selection of the temperature and pressure
conditions for the hydrolization reaction is capable of producing unexpected and
surprisingly superior results. More particularly, it is preferred according to this aspect of
the invention that the hydrolization reaction step (b) comprises reacting the oxime ether at
the a temperature that is above about the boiling point of the hydrolyzing agent and below the decomposition temperature of the hydoxylamine salt and below the decomposition
temperature of the oxime ether.
In highly preferred embodiments, the present methods comprise (a) reacting an
oxime with an alkylating agent in the presence of a solvent selected from the group
consisting of NMP, acetonitrile and combinations of these, to produce an oxime ether; and
(b) reacting at least a portion of the oxime ether with a hydrolizing agent at a temperature
above about the boiling point of the hydrolyzing agent and below the decomposition
temperatures of the oximε ether and desired hydoxylamine salt to form said hydroxylamine
salt.
Numerous unexpected advantages are associated with the methods of the present
invention. For example, a significant and surprising increase in purity and yield is realized
by producing compounds in accordance with the present invention. By synthesizing
compounds according to the present invention, it is possible to obtain a hyroxylamine yield
that is at least about 40% (on a mole basis), more preferably at least about 45 % , and even
more preferably at least about 50% . It is believed that the present methods are capable of
achieving yields even as high as 65 % or greater. As used herein, the term "yield" refers
generally to the amount of product produced expressed as a percentage of the theoretical
amount of product that could be produced by the reactions. Furthermore, the methods of
the present invention produce the desired hydroxylamine salts in much shorter periods of
time as compared to the prior art processes.
THE OXIME REACTION STEP
It is contemplated that any oxime reactant known in the art can be adapted for use in accordance with the present invention. A large number of oximes are commercially
available and/or are known in the literature to be obtainable by art-recognized procedures.
Although it is contemplated that oximes in general can be used to advantage in the
methods of the present invention, it is particularly preferred to use oximes as illustrated in
Formula I below:
R,(R2)-C=N-OH (I)
wherein R, and R2 are independently selected from the group consisting of hydrogen,
unsubstituted or substituted alkyl groups, unsubstituted or substituted cycloalkyl groups,
unsubstituted or substituted aryl groups and unsubstituted or substituted aralkyl groups.
R, or R2 as an unsubstituted or substituted alkyl group may be straight-chained or
branched, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, hexyl,
octyl, or decyl. Preferably, R, or R2 as an unsubstituted or substituted alkyl group is an
alkyl having about 1 to about 12 carbons, for example, methyl, ethyl, propyl, isopropyl,
butyl, isobutyl, pentyl or hexyl. More preferably, R, or R2 as an unsubstituted or
substituted alkyl group is either methyl or ethyl.
R, or R2 as an unsubstituted or substituted cycloalkyl may be, for example,
cyclopropyl, cyclobutyl, cyclopentyl, cyclopentadienyl, methylcyclopentyl, cyclohexyl,
methylcyclohexyl, dimethylcyclohexyl, cycloheptyl, and cyclohexyl. Preferably, R, or R2
as an unsubstituted or substituted cycloalkyl is cyclopentyl, cyclopentadienyl or cyclohexyl.
R, or R2 as an unsubstituted or substituted aryl group may be, for example, phenyl,
o-tolyl, -m-tolyl, -p-tolyl, -o-xylyl, -m-xylyl, -p-xylyl or napthyl. Preferably, R, or R2 as
an unsubstituted or substituted aryl group is an aryl group having about 6 to about 10 carbons, such as, phenyl or napthyl.
R, or R2 as an unsubstituted or substituted aralkyl group may be, for example,
benzyl, methylbenzyl, methoxybenzyl, diphenylmethyl, phenylethyl, or phenylpropyl.
Preferably, R, or R2 as an unsubstituted or substituted aralkyl group is an aralkyl having
about 7 to about 9 carbons, especially, benzyl.
Particularly preferred oximes include acetoxime, benzaldehyde oxime, and methyl
ethyl ketone oxime.
As mentioned above, the present invention involves reacting an oxime with "alkylating agent". As used herein, the term "alkylating agent" refers to any material capable of providing to the reaction a nucleophilic alkyl, aryl, aralkyl or cycloalkyl group capable of reacting with the oxime to form an oxime ether. The nucleophilic group provided by the alkylating agent or agents may be unsubstituted or subtituted and may contain heteroatoms. Examples of suitable alkylating agents include: 2-(N,N-Dimethylamino)ethyl chloride
hydrochloride, methyl chloride, ethyl chloride, propanyl chloride, isopropanyl chloride,
butyl chloride, benzyl chloride, benzyl bromide, phenyl chloride and phenyl bromide.
Preferred alkylating agents include: 2-(N,N-Dimethylamino)ethyl chloride hydrochloride,
methyl chloride and ethyl chloride. In a particularly preferred embodiment, the alkylating
agent comprises 2-(N,N-Dimethylamino)ethyl chloride hydrochloride.
The oxime alkylation reaction of the present invention is conducted under conditions effective to convert at least a portion of the oxime starting material, and preferably at least about 45 % (on a mole basis) of the oxime to oxime ether. In general, it is contemplated that the particular temperatures, pressures and other reaction conditions can vary widely within the scope of the present invention, depending on factors such as the particular starting material being used, the process equipment available and the particular hydroxylamine salt
that is desired.
It is highly preferred that the oxime alkylation reaction take place in an inert solvent. Generally, any known inert solvent can be used with some degree of effectiveness in accordance with the present invention. However, it is preferred that the oxime reaction is
effective to provide an oxime ether yield of at least about at least about 40% (on a mole
basis), more preferably at least about 45%, and even more preferably at least about 50% .
It is believed that the present methods are capable of achieving yields even as high as 65 %
or greater. The present inventors have surprisingly found that this desirable yield can be
achieved by selecting as the inert solvent either NMP, acetontrile, or combinations of these. It has been discovered that the use of these solvents affords a significant and substantial
increase in yields in the production of oxime ether in comparison to the solvents used in the
prior art. Although the applicants do not wish to be bound by or to any theory of
operation, it is believed that the solvents specified herein contribute to the surprising
increase in yield because the oxime reactants and the oxime salt intermediate formed are all
independently soluble to a highly favorable degree in the specified solvents. Furthermore,
undesirable halide salt side products formed in the oxime reaction (a) are generally
insoluble in the preferred solvents and precipitate out of the reaction solution. It is believed
that this in turn aids in the achieving a high degree of reaction completion in relatively short
reaction times.
It is contemplated that the other conditions for conducting the oxime reaction can be selected as required for each individual application in view of the description of the invention contained herein. With respect to the relative amounts of the oxime and alkylating agent to be used in the practice of the present invention, it is believed that this can vary widely depending on the particulars of each application, including the particular oxime starting material and the desired yield from the oxime reaction step (a). Preferably, the relative amount of starting materials used, together with the other process condition, as described herein, are effective to achieve a greater than 50% yield (on a mole basis) of oxime ether. For example, for preferred processes in which the oxime starting material comprises acetoxime and the alkylating agent is 2-(N,N-Dimethylamino)ethyl chloride hydrochloride,
the mole ratio of oxime to alkylating agent is preferably at least about 1:2, more preferably
at least about 1 : 1.5, and even more preferably at least about 1: 1.
According to certain preferred embodiments, the oxime reaction (a) comprises
reacting the oxime, the alkylating and a base in the presence of an inert solvent. Any
suitable base soluble in the solvent can be used. Examples of bases adaptable for use in
the present invention include: sodium hydroxide, potassium hydroxide, sodium carbonate,
potassium carbonate, and the like. In a preferred embodiment, the base comprises sodium
hydroxide or potassium hydroxide. Furthermore, applicants have discovered that bases
such as sodium hydroxide and potassium hydroxide are especially useful in the form of a
fine powder flake. Although applicants do not wish to be bound by or to any particular
theory of operation, it is believed that fine powder flakes more readily dissolve in the
reaction solvent and increase the reaction surface between the base, the alkylating agent and
oxime starting material, resulting in a shorter completion time for the reaction Accordingly, in a particularly preferred embodiment of the present invention, the base comprises a fine powder of sodium hydroxide or potassium hydroxide.
The relative amount of base to be used in the preferred practice of the present invention can also vary widely within the scope hereof. However, for preferred processes in which the oxime starting material comprises acetoxime and the alkylating agent is 2-(N,N-
Dimethylamino)ethyl chloride hydrochloride, the mole ratio of oxime to base is preferably
at least about 1 :4, preferably at least about 1 :3.25, and even more preferably at least about
1 :2.5.
Those skilled in the art will appreciate that the conditions under which the alkylation reaction occurs, including the pressure, temperature and period of reaction can vary widely within the scope hereof, depending on numerous factors, including the particular starting materials used. However, in general, it is believed oxime reactions of the present invention will require shorter periods of time to complete than prior art processes. For preferred processes in which the oxime starting material comprises acetoxime and the alkylating agent is 2-(N,N-Dimethylamino)ethyl chloride hydrochloride, it is preferred that the reaction time
of the alkylation reaction be about 10 hours or less. More preferably, the reaction time is about 8 hours or less, and even more preferably 6 hours or less. In view of the teachings contained herein, those skilled in the art will be able to select the appropriate reaction conditions to achieve the particular desired result. For preferred embodiments in which the oxime starting material is acetone oxime and the alkylating agent is 2-(N,N- Dimethylamino)ethyl chloride hydrochloride, the alkylating reaction is preferably carried
out at temperatures of from about 30 °C to about 150°C, more preferably from about 45 CC
to about 130°C, and even more preferably from about 60°C to about 75°C. Furthermore, the alkylating reaction is preferably carried out at pressures of from about 1 to about 3
atmospheres ("atm."), more preferably from about 1 to about 2 atm. and even more
preferably at about 1 atm.
The oxime ether compounds obtained from the aforementioned reaction may be
purified by conventional methods known to those skilled in the art. For example, aqueous
washes, drying, concentrating under reduced pressure, distillation, and the like may be
used to purify the oxime ether. In preferred embodiments, the products of reaction step (a)
of the present invention are purified using fractional distillation. In general, large amounts
of solvent, including up to about 95 % or more can be recovered during distillation and
recycled. In this manner the solvent cost is significantly reduced.
THE HYDROLYSIS REACTION
The second step of the present methods comprises reacting the oxime ether with a hydrolyzing agent to form the desired hydoxylamine salts. The preferred hyrolyzing agents according to the present invention comprise a liquid, and even more preferably an acid dissolved in a liquid solvent. In such embodiments, it is generally preferred that the step (b) comprises dissolving the oxime ether in the hydrolyzing agent and exposing the reactants to conditions effective to produce the desired hydroxlamine salt.
Any known acid and solvent used conventionally in acid-catalyzed hydrolysis reactions can be used in the present invention. Examples of acids suitable for use in the present invention include hydrochloric acid and sulfuric acid. For example, in a preferred embodiment wherein the oxime ether is 2-(N,N-Dimethylamino)ethyl acetoxime ether, the hydrolyzing agent comprises a 20% solution of hydrochloric acid in water. Those of skill in the art will be readily able, without undue experimentation, to select acids and solvents for
use in the hydrolysis step of the present invention.
Applicants have surprisingly found that vastly superior results can be achieved by utilizing a hydrolysis reaction temperature within a defined range. Thus, although the hydrolysis reaction may be conducted generally at temperatures used in prior art hydrolyses, applicants have discovered that by conducting the hydrolysis reaction at a temperature above the boiling point of the hydrolyzing agent, but below the decomposition temperatures of the oxime ether and the hydroxylamine salts, a significantly higher yield of product can be formed in a significantly shorter time than had been available with prior art processes. As used herein the term "decomposition temperature" of a compound refers generally to the temperature at which, under the reaction pressure, the compound breaks down into smaller constituents. Furthermore, the term "boiling point" as used herein means the initial boiling point of the hydrolyzing agent at the pressure of the reaction.
Although the applicants do not wish to be bound by or to any particular theory of operation, it is believed that at temperatures below the boiling point of the hydrolyzing agent, the reaction mixture will develop an undesirably high concentration of the ketone or aldehyde side-products, which are formed by hydrolyzing the carbon-nitrogen imine bond of the oxime ether. It is believed that the presence of these side products inhibits the formation of the desired hydroxylamine salts. As illustrated in the reaction equation below, the hydrolysis reaction is an equilibrium reaction.
oxime ether + acid + water .., - hydroxylamine salt + ketone/aldehyde Accordingly, the formation of the ketone or aldehyde side-product on the right side of the equation increases the concentration of side-product present and tends to drive the reaction towards the left, thus hindering formation of the desired product.
However, applicants believe that by conducting the hydrolysis reaction at a temperature sufficient to cause accelerated vaporization of the solvent in the hydrolyzing agent, the disfavored side-product is preferentially removed from the reaction mixture. In this manner, the conversion of oxime ether to hydroxylamine salt is much less hindered, and oxime ether can be converted to hydroxylamine salt at a faster rate and to a greater degree of completion.
It is also important to note that conducting the hydrolysis reaction at a temperature above the decomposition point of the oxime ether or the hydroxylamine salt product can be detrimental for a number of reasons. For instance, heating the reaction mixture above either decomposition point will break down the oxime ether starting material or the desired reaction product and significantly lower the reaction yield. Moreover, the decomposition of oxime ethers and/or hydroxylamine salts results often in the quick release of large quantities of ammonia gas, causing violent explosions. Accordingly, in preferred embodiments of the present invention, the temperature at which the hydrolysis reaction is conducted is maintained below the decomposition points of the oxime ether and the desired hydroxylamine salt.
To further ensure the safety and efficiency of the hydrolysis reaction, it is preferred
that the reflux temperature at which the reaction is conducted be at least 30 °C below the
lower of the decomposition points of the oxime ether and the desired hydroxylamine salt.
More preferably, the reflux temperature is at least 45 °C below the lower decomposition point, and even more preferably, 60 °C below. For example, for preferred processes in
which the oxime ether is 2-(N,N-Dimethylamino)ethyl acetoxime ether and the desired
hydroxylamine salt is O-[2-N,N-dimethylamino)ethyl]-hydroxylamine dihydrochloride, the
reaction temperature is preferably from about 105°C to about 120°C. More preferably, the
reaction temperature of the preferred processes is from about 108°C to about 115°C, and
even more preferably from about 110°C and 113°C.
The period of reaction can vary widely within the scope hereof, depending on numerous factors, including the particular starting materials used. However, in general, it is believed oxime ether reactions of the present invention will require shorter periods of time to complete than prior art processes. For preferred processes in which the oxime ether starting material comprises 2-(N,N-Dimethylamino)ethyl acetoxime, it is preferred that the reaction
time of the alkylation reaction be about 12 hours or less. More preferably, the reaction time is about 10 hours or less, and even more preferably 8 hours or less. In view of the teachings contained herein, those skilled in the art will be able to select the appropriate reaction conditions to achieve the particular desired result.
It is preferred that the hydrolysis reaction of the present invention be conducted according to the teachings hereof so as to provide an hydroxylamine salt yield of at least
about at least about 40% (on a mole basis), more preferably at least about 45 % , and even
more preferably at least about 50% . It is believed that the present methods are capable of
achieving yields even as high as 65 % or greater for the hydrolysis step.
The hydroxylamine salt compounds obtained from the aforementioned reaction may
be purified by conventional methods known to those skilled in the art. For example, aqueous washes, drying, concentrating under reduced pressure, distillation, and the like
may be used. In preferred embodiments, the hydrolysis reaction is carried out in a vessel
which is connected to or comprises distillation apparatus. Those of ordinary skill in the art
will be readily able to discern appropriate apparatus for removing distillate from the
hydrolysis reaction without undue experimentation.
In preferred embodiments, the hydroxylamine salt products of the present invention
are purified using recrystallization techniques. Techniques for recrystallizing compounds
within a variety of solvents are well-known in the art, and those of ordinary skill in the art
will readily be able to optimize known techniques to recrystallize and recover compounds
according to the present invention. Examples of recrystallization are disclosed in Perrin,
D.D; Armarego W.L.F., Purification of Laboratory Chemicals (3rd edition, Peragamon
Press 1988) (pp.12-16)., which is incorporated herein by reference. A particularly
preferred solvent for use in recrystallization of hydroxylamine salts is methanol.
Examples
In order to illustrate, in a non-limiting manner, the present invention is described in
connection with the following examples.
Example 1
This example illustrates the synthesis of 2-(N,N-Dimethylamino)ethyl acetoxime
ether (DMAE-AO) from acetoxime (AO) and 2-(N,N-Dimethylamino)ethyl chloride
hydrochloride.
To a jacketed 3-necked round-bottom flask (12L), equipped with a mechanical stirrer, a thermocouple and a condenser fixed with a nitrogen inlet/outlet, was charged 2.9
liters of acetonitrile (CH3CN). The acetonitrile was agitated using the mechanical stirrer.
Acetone oxime (511.6 g, 7.0 mol) was charged as one portion and the resulting mixture
was stirred at room temperature (25 °C) for 10 min. Sodium hydroxide flake (644.0 g,
16.4 mol) was added to the solution and the reaction was heated to 45 °C and agitated for
30 min. 2-(N,N-dimethylamino)ethyl chloride hydrochloride (1109.2 g, 7.7 mol) was
added in five portions (220 g/220mL CH3CN/10.0 min/per portion) over 50 min. After the
addition, the reaction was agitated at 65-70 °C for 1.5 hours and was then monitored by
gas chromatography (GC) to determine the disappearance of AO. The reaction was cooled to 25 °C, and the salt was filtered off under slight vacuum. The resulting cake was washed
once with CH3CN (0.2 L) and dried under vacuum. The combined filtrate of 2-(N,N-
dimethylamino)ethyl acetoxime ether product was held in a cold chamber prior to
distillation.
Next, to a fractional distillation unit comprising: a 3-necked round-bottom flask (5.0
L) equipped with a magnetic stirrer, a thermocouple, a fractional distillation column (10
theoretical plates) connected to a splitter and a timer, a condenser with vacuum line and
receivers, was added the aforementioned filtrate (3.0 L). The reflux rate was set as 1 : 1 and
the cooling fluid temperature was set at 0°C. The solution was heated to gentle reflux
(82°C) for 5 min, then the system pressure was gradually reduced from 756 to 600 rnmHg.
The remaining 2.0 L of filtrate was added to the distillation unit after 2.0 L of distillate
CHjCN was collected. The distillation was then continued until a total amount of 4.0 L of
distillate was gathered. The pot temperature was raised to 105°C and the vacuum was gradually decreased to 90 mmHg. The distillates (50mL/per cut) were checked carefully by
GC until the desired hydroxylamine salt product comprised 92% of the distillate. The
receiver was changed and the distillate was collected until the overhead temperature
dropped to 90° C. Then, the receiver was changed again and the vacuum was gradually
increased to 15 mmHg and several more cuts of distillates were collected, which were
sequentially checked by GC. Those cuts containing 97% or higher of DMAE-AO were
combined. A total of 632 g (56% yield) of DMAE-AO was obtained in>98% purity. The
fractions containing 75-92% DMAE-AO were combined and added to the next batch
distillation.
Example 2
This example illustrates the synthesis of O-[2-N,N-dimethylamino)ethyl]-
hydroxylamine dihydrochloride ("DMAEHA-2HC1") via the hydrolysis of DMAE-AO.
To a 3-necked round bottom flask (5.0L) equipped with a mechanical stirrer, a
thermocouple, a dropping funnel and a condenser connected to both a receiver and a caustic
scrubber (loaded with 25 % of aqueous NaOH solution), was added cooled (5°C) 20% HCl
solution (2795 g, 15.09 mol). The reaction mixture was cooled to 0°C and agitated.
DMAE-AO (750 g, 5.03 mol) was added slowly into the HCl solution and the jacket
temperature was controlled below 50° C. After the addition, the reaction jacket temperature
was set to 110-1 13 °C and the reaction was heated to boil. A distillate (2990 g) was
collected while 2810 g of 20% HCl was added to the reaction over 5-8 hours. The reaction was monitored by GC to determine the disappearance of DMAE-AO. After completion of
the hydrolysis, most of the water in the reaction distilled out (pot 113°C, overhead 113°C,
1350 g of water was collected). Then the reaction mixture was cooled to 100°C and n-
butanol (1.8L, b.p. 118°C) was added. The mixture was heated to reflux (jacket
temperature 118°C) for azeotropic distillation. Water (660 g) was collected from a Dean-
Stark trap while a homogeneous phase was formed. With mild agitation, the reaction was
cooled to 25 °C. The resulting pale-yellow crystals were filtered and dried under nitrogen
flow in a vacuum oven at 50°C for 16 hours to afford 865.5 g of crude product in 97.3 %
yield.
A portion of the aforementioned crystals (500 g) was placed in a 3-necked round-
bottom flask (5.0 L) equipped with a mechanical stirrer, a thermocouple and a condenser
connected to nitrogen inlet/outlet lines. Methanol (3.2 L) was added to the flask and the
resulting suspension was heated to 65 °C and refluxed for 20 min with mild agitation. A
portion of methanol (1.31 L, 41 % of total volume) was distilled out and the solution was
gradually cooled and seeded with high pure DMAEHA-2HC1 crystal at 60°C. The solution
was agitated at a moderate rate at 25 °C for 12 hours. The resulting crystals were filtered
off and dried under nitrogen flow in a vacuum oven at 50 °C for 12 hours to afford 410 g of
DMAEHA-2HC1 (68% yield) with 98.3 % purity. The mother liqueur was placed in cold
chamber (5°C) for 18 hours and 50.5 g of the second corps was obtained in 95.4% purity.
Having thus described a few particular embodiments of the invention, various alterations, modifications and improvements will readily occur to those skilled in the art. Such alterations, modifications and improvements as are made obvious by this disclosure are intended to be part of this description though not expressly stated herein, and are intended to be within the spirit and scope of the invention. Accordingly, the foregoing description is by way of example only, and not limiting. The invention is limited only as defined in the following claims and equivalents thereto.

Claims

CLAIMSWhat is claimed is:
1. A method for producing hydroxylamine salt comprising alkylating an oxime to produce an oxime ether and hydrolyzing said oxime ether to produce hydroxylamine salt, said alkylating and hydrolyzing steps being carried out under conditions effective to produce a hydroxylamine salt yield of at least about 40 % (on a mole basis).
2. The method of claim 1 wherein said oxime is of the formula:
R,(R2)-C =N-OH
wherein R{ and R2 are independently selected from the group consisting of hydrogen,
unsubstituted or substituted alkyl groups, unsubstituted or substituted cycloalkyl groups,
unsubstituted or substituted aryl groups and unsubstituted or substituted aralkyl groups.
3. The method of claim 1 wherein said alkylating step comprises reacting said
oxime
with an alkylating agent in the presence of a solvent.
4. The method of claim 3 wherein said solvent is selected from the group consisting of acetonitrile, l-methyl-2-pyrrolidinone ("NMP") and combinations thereof.
5. The method of claim 1, wherein the oxime is selected from the group consisting of acetone oxime, benzaldehyde oxime, methyl ethyl ketone oxime and combinations of two or more of these.
6. The method of claim 3 wherein the alkylating agent is selected from the group consisting of 2-(N,N-Dimethylamino)ethyl chloride hydrochloride, methyl chloride, ethyl chloride and combinations of two or more of these.
7. The method of claim 3 wherein said alkylating step comprises reacting said alkylating agent with said oxime in the presence of a base dissolved in said solvent.
8. The method of claim 7 wherein said base used is selected from the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate and combinations of two or more of these.
9. The method of claim 7 wherein said base comprised a fine powder flake prior to dissolution in said solvent.
10. The method of claim 1 further comprising the step of purifying said hydroxylamine salt by recrystallization.
11. The method of claim 1 wherein said alkylation step produces an oxime ether yield of at least about 45%> (on a mole basis) in a reaction time of no greater than about 6 hours.
12. The method of claim 11 wherein said alkylating step comprises reacting said
oxime with an alkylating agent in the presence of a solvent selected from the group
consisting of acetonitrile, 1 -methyl-2-pyrrolidinone ("NMP") and combinations thereof.
13. The method of claim 1 wherein said wherein said hydro lyzation produces an hydroxylamine salt yield of at least about 45% (on a mole basis) in a reaction time of no greater than about 8 hours.
14. The method of claim 13 wherein said hydrolyzation step comprises reacting said oxime ether with a liquid hydrolyzing agent at a temperature above about the boiling temperature of the hydrolyzing agent and below about the lower of the decomposition temperatures of said hydroxylamine salt and said oxime ether.
15. The method of claim 14, wherein said temperature is at least about 30 degrees below the decomposition temperature of said oxime ether.
16. The method of claim 14, wherein said temperature is at least about 30 degrees below the decomposition temperature of said hydroxylamine salt.
17. The method of claim 13 wherein the hydrolyzing agent comprises a solution of HCl in water and said hydrolyzation temperature is from about 105°C to about 120°C.
18. The method of claim 17 wherein said hydrolyzation step forms said hydroxylamine salt and a side product of the formula R,(R2)-C=O and wherein said
hydrolysis step comprises removing said side product from the reaction mixture by distillation.
19. A method for producing a hydroxylamine salt comprising alkylating an oxime
in the presence of a solvent selected from the group consisting of acetonitrile, l-methyl-2- pyrrolidinone and mixtures thereof, to form an oxime ether and reacting said oxime ether with a hydrolyzing agent at a temperature above about the boiling temperature of the hydrolyzing agent and below about the decomposition temperatures of said hydroxylamine salt and said oxime ether to produce a hydroxylamine salt.
20. The method of claim 19 wherein said oxime is of the formula:
R,(R2)-C=N-OH
wherein R, and R2 are independently selected from the group consisting of hydrogen,
unsubstituted or substituted alkyl groups, unsubstituted or substituted cycloalkyl groups,
unsubstituted or substituted aryl groups and unsubstituted or substituted aralkyl groups.
21. The method of claim 20 wherein the oxime is selected from the group consisting of acetone oxime, benzaldehyde oxime, methyl ethyl ketone oxime and combinations of two or more of these.
22. The method of claim 19 wherein said alkylating step comprises reacting said
oxime with an alkylating agent in said solvent, said alkylating agent being selected from the
group consisting of 2-(N,N-Dimethylamino)ethyl chloride hydrochloride, methyl chloride, ethyl chloride and combinations of two or more of these.
23. The method of claim 22 wherein said alkylating step comprises reacting said alkylating agent with said oxime in the presence of a base dissolved in said solvent.
24. The method of claim 19 wherein said alkylation step produces an oxime ether yield of at least about 50% (on a mole basis) in a reaction time of no greater than about 6 hours.
25. The method of claim 19 wherein said wherein said hydrolyzation produces an hydroxylamine salt yield of at least about 50% (on a mole basis) in a reaction time of no greater than about 8 hours.
26. The method of claim 19 wherein the hydrolyzing agent comprises a solution of HCl in water and said hydrolyzation temperature is from about 105°C to about 120°C.
27. A method for producing a hydroxylamine salt comprising alkylating an oxime
in the presence of a solvent selected from the group consisting of acetonitrile, l-methyl-2- pyrrolidinone and mixtures thereof, to form an oxime ether and hydrolyzing said oxime ether to produce hydroxylamine salt.
28. A method for producing a hydroxylamine salt comprising alkylating an oxime to produce an oxime ether and reacting said oxime ether with a hydrolyzing agent at a temperature above about the boiling temperature of the hydrolyzing agent and below about the decomposition temperatures of said hydroxylamine salt and said oxime ether to produce a hydroxylamine salt.
PCT/US2000/017155 1999-06-23 2000-06-22 Method of making hydroxylamine salts WO2000078710A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU56318/00A AU5631800A (en) 1999-06-23 2000-06-22 Method of making hydroxylamine salts

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14053399P 1999-06-23 1999-06-23
US60/140,533 1999-06-23
US57889100A 2000-05-26 2000-05-26
US09/578,891 2000-05-26

Publications (2)

Publication Number Publication Date
WO2000078710A1 true WO2000078710A1 (en) 2000-12-28
WO2000078710A8 WO2000078710A8 (en) 2001-06-28

Family

ID=26838264

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/017155 WO2000078710A1 (en) 1999-06-23 2000-06-22 Method of making hydroxylamine salts

Country Status (1)

Country Link
WO (1) WO2000078710A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0023560A1 (en) * 1979-07-05 1981-02-11 BASF Aktiengesellschaft Process for preparing O-substituted ketoximes
GB1601752A (en) * 1977-03-02 1981-11-04 Ciba Geigy Ag Oxime derivatives and their preparation
WO1996004238A1 (en) * 1994-08-02 1996-02-15 Basf Aktiengesellschaft Preparation of o-(2-hydroxyalkyl) oximes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601752A (en) * 1977-03-02 1981-11-04 Ciba Geigy Ag Oxime derivatives and their preparation
EP0023560A1 (en) * 1979-07-05 1981-02-11 BASF Aktiengesellschaft Process for preparing O-substituted ketoximes
WO1996004238A1 (en) * 1994-08-02 1996-02-15 Basf Aktiengesellschaft Preparation of o-(2-hydroxyalkyl) oximes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
F.J. VILLANI: "Oximino ethers: Dialkylaminoalkyl derivatives", JOURNAL OF PHARMACEUTICAL SCIENCES., vol. 58, no. 1, 1969, WASHINGTON US, pages 138 - 141, XP002151041 *
MÜLLER: "Methoden der organischen Chemie; Band X/1: Stickstoffverbindungen I, Teil 1", 1971, GEORG THIEME ERLAG, STUTTGART, XP002151042 *
R.G. KONSTYANOVSKII ET AL.: "Asymmetric nonbridged nitrogen. communication 29. Synthesis and study of the dimethylester of 15N-alkoxyaziridine-2,2-dicarboxylic acid", BULLETIN OF THE ACADEMY OF SCIENCES OF THE USSR. DIVISION OF CHEMICAL SCIENCE., vol. 32, 1983, CONSULTANTS BUREAU. NEW YORK., US, pages 1421 - 1427, XP002151046 *

Also Published As

Publication number Publication date
WO2000078710A8 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
EP2906531B1 (en) Compounds useful in the synthesis of benzamide compounds
JPWO2002032854A1 (en) Method for producing nateglinide crystals
US4496736A (en) Process for the preparation of carboxylic acids and N-tert.-alkylamines
JPS63152350A (en) Production of o-substituted hydroxylamine-hydrochloride
JP4097291B2 (en) Method for producing substituted valinamide derivative
WO2000078710A1 (en) Method of making hydroxylamine salts
US6087499A (en) Process for producing 5-perfluoroalkyluracil derivatives
JPH0115497B2 (en)
KR20170108080A (en) Methods for the preparation of compounds such as 3-arylbutanal which are useful in the synthesis of medetomidine
JP3595110B2 (en) Method for nitrosating C—H-acid compounds
JP3319020B2 (en) Process for producing N- (α-hydroxyethyl) formamide and N- (α-alkoxyethyl) formamide
JPH039898B2 (en)
JP3640319B2 (en) Method for producing benzamide derivative
JPH0262854A (en) Production of substituted phenoxyethylamines
US3346634A (en) Process for the preparation of nu-substituted amides of diphenylacetic acid
US4010160A (en) Process for the manufacture of 1,3-bis-(β-ethylhexyl)-5-amino-5-methyl-hexahydropyrimidine
EA036663B1 (en) Method for preparing azoxystrobin
WO1998005630A1 (en) Process for the preparation of organic nitriles
CN112608247B (en) Preparation method of capsaicin and capsaicin prepared by using same
JP2005060302A (en) Method for producing n-methacryloyl-4-cyano-3-trifluoromethylaniline and method for stabilizing the same
JP3700190B2 (en) Process for producing 2-indanylmethylamine, N-benzyl-N- (2-indanylmethyl) amine and process for producing the same
US4224246A (en) Process for the synthesis and separation of the threo and erythro isomers of 2-amino-1-phenyl-1-propanol
US6051732A (en) Process for the preparation of 3-acetoxy-2-methylbenzoyl chloride
JP3175334B2 (en) Method for producing N- (α-alkoxyethyl) -carboxylic acid amide
JPH10505602A (en) How to make selegiline

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 52/2000 UNDER (30) REPLACE "NOT FURNISHED" BY "09/578891"

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP